000 01225 a2200313 4500
005 20250514183443.0
264 0 _c20041102
008 200411s 0 0 eng d
022 _a0305-1870
024 7 _a10.1111/j.1440-1681.2004.03982.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnjaneyulu, Muragundla
245 0 0 _aQuercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats.
_h[electronic resource]
260 _bClinical and experimental pharmacology & physiology
_cApr 2004
300 _a244-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xtherapeutic use
650 0 4 _aDiabetic Nephropathies
_xdrug therapy
650 0 4 _aFlavonoids
_xtherapeutic use
650 0 4 _aKidney Failure, Chronic
_xdrug therapy
650 0 4 _aMale
650 0 4 _aQuercetin
_xtherapeutic use
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
700 1 _aChopra, Kanwaljit
773 0 _tClinical and experimental pharmacology & physiology
_gvol. 31
_gno. 4
_gp. 244-8
856 4 0 _uhttps://doi.org/10.1111/j.1440-1681.2004.03982.x
_zAvailable from publisher's website
999 _c14770241
_d14770241